DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Garber A, Henry R, Ratner R et al.
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 mono): a randomised, 52-week, Phase III, double-blind, parallel-treatment trial.
Lancet 2009;
373: 473-481
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.